Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

Pharmaceutical Preparations CA, United States
Nasdaq: DVAX
Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company, which discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The company's product candidates is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than currently licensed vaccines. Dynavax Technologies was founded on August 29, 1996 by Dennis A. Carson, Eyal Raz and Lawrence M. Lichtenstein and is headquartered in Berkeley, CA.
Similar to: Mast Therapeutics, Inc., Columbia Laboratories, Inc., Hutchison China MediTech Ltd.
Covington, LA, US
Pool Corp. markets and distributes swimming pool supplies and related products. It offers maintenance products, repair & replacement… Learn more →

Hong Kong, HK
Hutchison China MediTech Ltd. is a holding company, which engages in the manufacture, distribution, and sale of traditional Chinese… Learn more →

Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →

San Diego, CA, US
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging… Learn more →